“Immune Checkpoint Inhibitor-Associated Myocarditis Presenting as Isolated High-Grade Atrioventricular Block: A Review of Surveillance Strategies” (2022) Journal of Clinical Case Studies and Reviews, 3(1), pp. 31–36. doi:10.5281/zenodo.22205984.